By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AnaptysBio, Inc. 

10835 Road to the Cure
Suite 100
San Diego  California  92121  U.S.A.
Phone: 858-362-6295 Fax: 858-362-6296


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





Company News
AnaptysBio, Inc. Appoints Dr. Marco Londei To Newly Created Chief Development Officer Position Clinical Immunologist To Lead Anaptysbio's Pipeline Advancement 10/20/2014 9:00:14 AM
Momenta Pharmaceuticals, Inc. (MNTA) Exercises Option To Acquire Novel Antibodies From AnaptysBio, Inc. 9/8/2014 7:01:10 AM
AnaptysBio, Inc. Announces Issuance Of United States Patent Covering Proprietary Antibody Humanization Technology 4/3/2014 9:32:54 AM
Tesaro, Inc. (TSRO), AnaptysBio, Inc. Strike Immuno-Oncology Pact Worth $125 Million 3/13/2014 7:02:32 AM
AnaptysBio, Inc. Announces Development Of Novel Anti-IL33 Therapeutic Antibody 1/10/2014 10:37:15 AM
AnaptysBio, Inc. Announces Antibody Development Agreement With Momenta Pharmaceuticals, Inc. (MNTA) 12/17/2013 10:44:30 AM
AnaptysBio, Inc. Receives Allowance of US Patent Covering Proprietary ABELmAb™ Libraries 10/17/2013 9:54:32 AM
AnaptysBio, Inc. Awarded U.S. Government Contract to Develop Anti-Ricin Antibodies 5/17/2013 8:52:05 AM
AnaptysBio, Inc. Develops Novel Antibody Scaffold With Extreme Thermostability 12/4/2012 9:42:31 AM
AnaptysBio, Inc. Expands Patent Portfolio with Issuance of U.S. Patent to in Vitro Somatic Hypermutation 10/18/2012 10:49:52 AM
1234
//-->